Fingerprint
Dive into the research topics of 'A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically